These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1133 related articles for article (PubMed ID: 19391293)

  • 1. Fungal nail infections: diagnosis and management.
    Prescrire Int; 2009 Feb; 18(99):26-30. PubMed ID: 19391293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral antifungal medication for toenail onychomycosis.
    Kreijkamp-Kaspers S; Hawke K; Guo L; Kerin G; Bell-Syer SE; Magin P; Bell-Syer SV; van Driel ML
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD010031. PubMed ID: 28707751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement.
    Baran R; Sigurgeirsson B; de Berker D; Kaufmann R; Lecha M; Faergemann J; Kerrouche N; Sidou F
    Br J Dermatol; 2007 Jul; 157(1):149-57. PubMed ID: 17553051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
    Gupta AK
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis.
    Avner S; Nir N; Henri T
    J Dermatolog Treat; 2005; 16(5-6):327-30. PubMed ID: 16428154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toenail onychomycosis: current and future treatment options.
    Finch JJ; Warshaw EM
    Dermatol Ther; 2007; 20(1):31-46. PubMed ID: 17403258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of nail mycoses].
    Büchner SA
    Ther Umsch; 1998 Aug; 55(8):503-8. PubMed ID: 9757817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of oral antifungal agents to treat onychomycosis.
    Gupta AK; Ryder JE
    Dermatol Clin; 2003 Jul; 21(3):469-79, vi. PubMed ID: 12956199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment options--development of consensus guidelines.
    Lecha M; Effendy I; Feuilhade de Chauvin M; Di Chiacchio N; Baran R;
    J Eur Acad Dermatol Venereol; 2005 Sep; 19 Suppl 1():25-33. PubMed ID: 16120203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The systemic treatment of onychomycosis.
    Wenig JA
    Clin Podiatr Med Surg; 1995 Apr; 12(2):263-74. PubMed ID: 7600500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial.
    Grover C; Bansal S; Nanda S; Reddy BS; Kumar V
    Br J Dermatol; 2007 Aug; 157(2):364-8. PubMed ID: 17573877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of amorolfine nail lacquer for the prophylaxis of onychomycosis over 3 years.
    Sigurgeirsson B; Olafsson JH; Steinsson JT; Kerrouche N; Sidou F
    J Eur Acad Dermatol Venereol; 2010 Aug; 24(8):910-5. PubMed ID: 20028447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of onychomycosis therapy may involve a combination of approaches.
    Hay RJ
    Br J Dermatol; 2001 Oct; 145 Suppl 60():3-8. PubMed ID: 11777262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of antifungal therapy and the severity index for assessing onychomycosis: part I.
    Baran R; Hay RJ; Garduno JI
    J Dermatolog Treat; 2008; 19(2):72-81. PubMed ID: 18484426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical amorolfine for 15 months combined with 12 weeks of oral terbinafine, a cost-effective treatment for onychomycosis.
    Baran R
    Br J Dermatol; 2001 Oct; 145 Suppl 60():15-9. PubMed ID: 11777260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy.
    Baran R; Kaoukhov A
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):21-9. PubMed ID: 15649187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The new oral antifungal agents for onychomycosis of the toenails.
    Gupta AK; Shear NH
    J Eur Acad Dermatol Venereol; 1999 Jul; 13(1):1-13. PubMed ID: 10565624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of systemic antimycotics in dermatotherapy.
    Niewerth M; Korting HC
    Eur J Dermatol; 2000 Mar; 10(2):155-60. PubMed ID: 10694319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciclopirox nail lacquer for the treatment of onychomycosis: an open non-comparative study.
    Shemer A; Nathansohn N; Trau H; Amichai B; Grunwald MH
    J Dermatol; 2010 Feb; 37(2):137-9. PubMed ID: 20175847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis.
    Arca E; Taştan HB; Akar A; Kurumlu Z; Gür AR
    J Dermatolog Treat; 2002 Mar; 13(1):3-9. PubMed ID: 12006131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.